Gosset Ownership
Private
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Advanced Medicine Partners General Information
Advanced Medicine Partners provides industry-leading process development, manufacturing, analytical development, and testing services for advanced medicines—especially viral vectors used in gene and cell therapies. Their proprietary AAV platform delivers high purity products with best-in-class functional full capsid ratios. The team has supported over 400 non-GMP batches and more than 20 preclinical studies including IND-enabling efficacy/toxicology work for clients. They are recognized for their operational experience from leading biotech companies such as Jaguar Gene Therapy, AveXis/Novartis, Amgen.
Contact Information
Drug Pipeline
JAG201
Pre-clinicalKey Partnerships
Not specifically disclosed publicly as of June 2025.
Advanced Medicine Partners Funding
No funding data available
To view Advanced Medicine Partners's complete valuation and funding history, request access »